The FDA approved the first posterior motion-preserving device for degenerative disc disease, while DiscGenics, Angitia, and BioRestorative advanced late-stage trials. ReGelTec reported positive HYDRAFIL data and CE Mark approval.
Five intra-articular gene therapy platforms for knee osteoarthritis are in human trials in the US, while India prepares regulatory guidelines for mRNA, gene and cell therapies to accelerate innovation.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07641504 |
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain |
RECRUITING | PHASE2 |
| NCT07543835 |
Comparing Yoga Nidra, Yoga, and Control Condition on Pain in Individuals With Chronic Low Back Pain |
RECRUITING | NA |
| NCT07190807 |
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control |
RECRUITING | NA |
